Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...
Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...
In May 2017, Outsourcing-Pharma.com conducted its inaugural “state of the industry” survey of its user base of pharmaceutical industry professionals, including...
Recipharm AB | 15-May-2017
| Technical / White Paper
Selecting and developing an appropriate dosage form for inhalation products can be challenging. The physicochemical properties of the API, the required...
Baxter BioPharma Solutions | Recorded the 01-Jun-2017 | Webinar
Antibody-drug conjugates (ADCs) were developed to target the delivery of chemotherapeutic agents and greatly reduce the quantity of chemotherapeutic agent...
You have the power to make a difference. To make new therapeutics that improve quality of life and inspire a healthier world. To do this, you need a manufacturing...
A controlled document distribution process, in which getting the right information to the intended recipients within a required time frame and being able...
The EU and US deadlines for serialisation are looming and pharmaceutical companies need to be prepared in order to ensure compliance. Implementing serialisation...
Marken maximizes efficiency and enhances service offerings while continuing to specialize in the high-touch, personalized services that the company is...
Baxter BioPharma Solutions’ award-winning facility in Bloomington, Indiana, USA, is one of the largest contract manufacturers of injectable sterile products...
Catalent Pharma Solutions | 23-Jan-2017
| Technical / White Paper
Clinical trials are more complex than ever before, driving the industry to develop and adopt new ways to manage clinical supplies and address new challenges.Fast...
Finding more efficient ways to target drug delivery to the small intestine and provide effective enteric protection for heat or acid-sensitive and/or gastric-irritating...
As more approved biologics near patent expiration, the race to be first to market with a biosimilar alternative will intensify. Delays encountered during...
Regulatory control of elemental impurities in pharmaceutical products has long been discussed, with both the European Pharmacopeia (EP) and the United...
